NCT00783224View on ClinicalTrials.gov

A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512)

PHASE3CompletedINTERVENTIONAL
Enrollment

351

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

November 30, 2005

Study Completion Date

December 31, 2005

Conditions
Perennial Allergic Rhinitis
Interventions
DRUG

Placebo for MF

Placebo to mometasone furoate nasal spray, indistinguishable from mometasone furoate nasal spray. Patients in this arm take 2 sprays per nostril once a day for 2 weeks

DRUG

Placebo for FP

Placebo to fluticasone nasal spray, indistinguishable from fluticasone propionate nasal spray. Patients in this arm take 2 sprays per nostril twice a day for 2 weeks

DRUG

Mometasone

Mometasone furoate nasal spray. Patients in this arm take 2 sprays per nostril once a day for 2 weeks

DRUG

Fluticasone

Fluticasone propionate nasal spray. Patients in this arm take 2 sprays per nostril twice a day for 2 weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00783224 - A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512) | Biotech Hunter | Biotech Hunter